Efficacy and Safety of Biphasic Insulin Aspart 30/70 in Type 2 Diabetes Suboptimally Controlled on Oral Antidiabetic Therapy in Korea: A Multicenter, Open-Label, Single-Arm Study

Efficacy and Safety of Biphasic Insulin Aspart 30/70 in Type 2 Diabetes Suboptimally Controlled on Oral Antidiabetic Therapy in Korea: A Multicenter, Open-Label, Single-Arm Study

BackgroundThe purpose of this study was to evaluate change in glycosylated hemoglobin (HbA1c), side effects, and quality of life (QOL) after a 16-week treatment period with Biphasic insulin aspart 30/70 (BIasp30) in patients with type 2 diabetes mellitus (T2DM) who had been suboptimally controlled w...

Full description

Bibliographic Details
Main Authors: Kee-Ho Song, Jung Min Kim, Jung-Hyun Noh, Yongsoo Park, Hyun-Shik Son, Kyong Wan Min, Kyung Soo Ko
Format: Article
Language:English
Published: Korean Diabetes Association 2013-04-01
Series:Diabetes & Metabolism Journal
Subjects:
Diabetes mellitus, type 2
Glycemic control
Insulin aspart, insulin aspart protamine drug combination 30:70
Online Access:http://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-37-117.pdf

Internet

http://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-37-117.pdf

Similar Items